Literature DB >> 16579717

Impact of cognitive behavior therapy on health-related quality of life among adult hypnotic users with chronic insomnia.

Simon Dixon1, Kevin Morgan, Nigel Mathers, Joanne Thompson, Maureen Tomeny.   

Abstract

Results were combined from representative surveys of health related quality of life (HRQoL; n=11,877; age range=16-104) with data from a randomized controlled trial of cognitive behavior therapy for chronic insomnia (n=209; age range=31-92). Secondary analyses of scores from the SF-36 measure of HRQoL were conducted in order: (a) to compare the health related quality of life profiles of adult hypnotic users with chronic insomnia with those of population norms, and (b) to assess the impact of cognitive behavior therapy (CBT) for insomnia on HRQoL outcomes over 6 months. Compared with the primary care reference values, HRQoL among the trial participants at baseline was generally poorer. The magnitude of these decrements reduced markedly with advancing age. In the evaluation of the CBT intervention, statistically significant differences in SF-36 scores in favor of the intervention were present for physical functioning, emotional role limitation, and mental health over 6 months. Overall, this study shows that the SF-36 can play an important role in describing HRQoL in this patient group, and in the evaluation of interventions within this group.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16579717     DOI: 10.1207/s15402010bsm0402_1

Source DB:  PubMed          Journal:  Behav Sleep Med        ISSN: 1540-2002            Impact factor:   2.964


  6 in total

1.  Quality of life in patients suffering from insomnia.

Authors:  Waguih W Ishak; Kara Bagot; Shannon Thomas; Naira Magakian; Dina Bedwani; David Larson; Alexandra Brownstein; Christine Zaky
Journal:  Innov Clin Neurosci       Date:  2012-10

2.  Effect of Digital Cognitive Behavioral Therapy for Insomnia on Health, Psychological Well-being, and Sleep-Related Quality of Life: A Randomized Clinical Trial.

Authors:  Colin A Espie; Richard Emsley; Simon D Kyle; Christopher Gordon; Christopher L Drake; A Niroshan Siriwardena; John Cape; Jason C Ong; Bryony Sheaves; Russell Foster; Daniel Freeman; Joan Costa-Font; Antonia Marsden; Annemarie I Luik
Journal:  JAMA Psychiatry       Date:  2019-01-01       Impact factor: 21.596

3.  The societal costs of insomnia.

Authors:  Alan G Wade
Journal:  Neuropsychiatr Dis Treat       Date:  2010-12-20       Impact factor: 2.570

4.  Greater incidence of depression with hypnotic use than with placebo.

Authors:  Daniel F Kripke
Journal:  BMC Psychiatry       Date:  2007-08-21       Impact factor: 3.630

Review 5.  Co-Morbidity, Mortality, Quality of Life and the Healthcare/Welfare/Social Costs of Disordered Sleep: A Rapid Review.

Authors:  Sergio Garbarino; Paola Lanteri; Paolo Durando; Nicola Magnavita; Walter G Sannita
Journal:  Int J Environ Res Public Health       Date:  2016-08-18       Impact factor: 3.390

Review 6.  Sleep, Health and Wellness at Work: A Scoping Review.

Authors:  Nicola Magnavita; Sergio Garbarino
Journal:  Int J Environ Res Public Health       Date:  2017-11-06       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.